The article by Beatty et al demonstrated an independent association between high-sensitivity cardiac troponin T levels and recurrent events among patients with known stable coronary artery disease, even after controlling for important potential confounders, including structural and functional heart disease factors. This association implies that we have the capability to refine risk prediction further among such already high-risk patients. However, whether we should do so is another question, because it is unclear how such information would change clinical management. Patients with low troponin levels still had a high risk for recurrent events (an approximately 20% 10-year risk), and would not warrant cessation of conventionally accepted treatments for the prevention of recurrent events. Among patients with high troponin levels, one can consider having a more nuanced discussion about prognosis, or consider enrollment in clinical trials to assess new advances in the secondary prevention of coronary syndromes; but whether this results in improved patient-centered outcomes is unknown. As is the case with obtaining any new clinical information, we would not recommend the routine use of this laboratory test unless the results are tied to an evidence-based management decision that leads to improved outcomes, and the patient is adequately informed of its uncertain utility.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.